Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats

Anne M. Dorrance, Delyth Graham, R Clinton Webb, Robert Fraser, Anna Dominiczak

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Cell membrane composition and fluidity are altered in hypertension. Previous reports suggest arachidonic acid, a metabolically active fatty acid, is increased in the membranes of hypertensive animals compared to control. This increase in unsaturated fatty acids does not explain the observed reduction in fluidity in hypertensive rats, suggesting some other factors affecting fluidity may be present. It has been suggested that the metabolism of sphingomyelin is altered in genetic hypertension. We hypothesized that membrane sphingomyelin content is increased in hypertensive animals. Procedures: Stroke-prone spontaneously hypertensive rats (n = 8) were compared with Wistar-Kyoto rats (n = 8). Erythrocyte membranes were prepared and the lipids extracted and separated. Fatty acid methyl esters were produced, identified, and quantified by gas chromatography-mass spectrometry; membrane lipid content was also assessed. Results: The concentration of sphingomyelin was higher in the membrane of the hypertensive rats (45.7 ± 6 v 22.4 ± 2 μg/mg of protein) compared to control. The previously observed increase in membrane arachidonic acid content was observed in hypertensive animals when compared to control (130 ± 32 v 40 ± 3 μg/mg of protein). However, this difference was confined to the phosphatidylinositol (18 ± 4 v 6.5 ± 1.5 μg/mg of protein) and free fatty acid (2.1 ± 0.4 v 0.6 ± 0.1 μg/mg of protein) fractions. Conclusion: We hypothesize that reports of reduced membrane fluidity observed in hypertension may be due to an increase in the proportion of sphingomyelin in the cell membrane.

Original languageEnglish (US)
Pages (from-to)1149-1153
Number of pages5
JournalAmerican journal of hypertension
Volume14
Issue number11 I
DOIs
StatePublished - Nov 15 2001

Fingerprint

Sphingomyelins
Inbred SHR Rats
Arachidonic Acid
Stroke
Membrane Fluidity
Membranes
Hypertension
Proteins
Fatty Acids
Cell Membrane
Inbred WKY Rats
Erythrocyte Membrane
Membrane Lipids
Phosphatidylinositols
Unsaturated Fatty Acids
Nonesterified Fatty Acids
Gas Chromatography-Mass Spectrometry
Esters
Lipids

Keywords

  • Erythrocytes
  • Genetic hypertension
  • Membrane lipids

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats. / Dorrance, Anne M.; Graham, Delyth; Webb, R Clinton; Fraser, Robert; Dominiczak, Anna.

In: American journal of hypertension, Vol. 14, No. 11 I, 15.11.2001, p. 1149-1153.

Research output: Contribution to journalArticle

Dorrance, Anne M. ; Graham, Delyth ; Webb, R Clinton ; Fraser, Robert ; Dominiczak, Anna. / Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats. In: American journal of hypertension. 2001 ; Vol. 14, No. 11 I. pp. 1149-1153.
@article{f3f4017bddb14deaba02cb9eb8149c81,
title = "Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats",
abstract = "Background: Cell membrane composition and fluidity are altered in hypertension. Previous reports suggest arachidonic acid, a metabolically active fatty acid, is increased in the membranes of hypertensive animals compared to control. This increase in unsaturated fatty acids does not explain the observed reduction in fluidity in hypertensive rats, suggesting some other factors affecting fluidity may be present. It has been suggested that the metabolism of sphingomyelin is altered in genetic hypertension. We hypothesized that membrane sphingomyelin content is increased in hypertensive animals. Procedures: Stroke-prone spontaneously hypertensive rats (n = 8) were compared with Wistar-Kyoto rats (n = 8). Erythrocyte membranes were prepared and the lipids extracted and separated. Fatty acid methyl esters were produced, identified, and quantified by gas chromatography-mass spectrometry; membrane lipid content was also assessed. Results: The concentration of sphingomyelin was higher in the membrane of the hypertensive rats (45.7 ± 6 v 22.4 ± 2 μg/mg of protein) compared to control. The previously observed increase in membrane arachidonic acid content was observed in hypertensive animals when compared to control (130 ± 32 v 40 ± 3 μg/mg of protein). However, this difference was confined to the phosphatidylinositol (18 ± 4 v 6.5 ± 1.5 μg/mg of protein) and free fatty acid (2.1 ± 0.4 v 0.6 ± 0.1 μg/mg of protein) fractions. Conclusion: We hypothesize that reports of reduced membrane fluidity observed in hypertension may be due to an increase in the proportion of sphingomyelin in the cell membrane.",
keywords = "Erythrocytes, Genetic hypertension, Membrane lipids",
author = "Dorrance, {Anne M.} and Delyth Graham and Webb, {R Clinton} and Robert Fraser and Anna Dominiczak",
year = "2001",
month = "11",
day = "15",
doi = "10.1016/S0895-7061(01)02188-4",
language = "English (US)",
volume = "14",
pages = "1149--1153",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "11 I",

}

TY - JOUR

T1 - Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats

AU - Dorrance, Anne M.

AU - Graham, Delyth

AU - Webb, R Clinton

AU - Fraser, Robert

AU - Dominiczak, Anna

PY - 2001/11/15

Y1 - 2001/11/15

N2 - Background: Cell membrane composition and fluidity are altered in hypertension. Previous reports suggest arachidonic acid, a metabolically active fatty acid, is increased in the membranes of hypertensive animals compared to control. This increase in unsaturated fatty acids does not explain the observed reduction in fluidity in hypertensive rats, suggesting some other factors affecting fluidity may be present. It has been suggested that the metabolism of sphingomyelin is altered in genetic hypertension. We hypothesized that membrane sphingomyelin content is increased in hypertensive animals. Procedures: Stroke-prone spontaneously hypertensive rats (n = 8) were compared with Wistar-Kyoto rats (n = 8). Erythrocyte membranes were prepared and the lipids extracted and separated. Fatty acid methyl esters were produced, identified, and quantified by gas chromatography-mass spectrometry; membrane lipid content was also assessed. Results: The concentration of sphingomyelin was higher in the membrane of the hypertensive rats (45.7 ± 6 v 22.4 ± 2 μg/mg of protein) compared to control. The previously observed increase in membrane arachidonic acid content was observed in hypertensive animals when compared to control (130 ± 32 v 40 ± 3 μg/mg of protein). However, this difference was confined to the phosphatidylinositol (18 ± 4 v 6.5 ± 1.5 μg/mg of protein) and free fatty acid (2.1 ± 0.4 v 0.6 ± 0.1 μg/mg of protein) fractions. Conclusion: We hypothesize that reports of reduced membrane fluidity observed in hypertension may be due to an increase in the proportion of sphingomyelin in the cell membrane.

AB - Background: Cell membrane composition and fluidity are altered in hypertension. Previous reports suggest arachidonic acid, a metabolically active fatty acid, is increased in the membranes of hypertensive animals compared to control. This increase in unsaturated fatty acids does not explain the observed reduction in fluidity in hypertensive rats, suggesting some other factors affecting fluidity may be present. It has been suggested that the metabolism of sphingomyelin is altered in genetic hypertension. We hypothesized that membrane sphingomyelin content is increased in hypertensive animals. Procedures: Stroke-prone spontaneously hypertensive rats (n = 8) were compared with Wistar-Kyoto rats (n = 8). Erythrocyte membranes were prepared and the lipids extracted and separated. Fatty acid methyl esters were produced, identified, and quantified by gas chromatography-mass spectrometry; membrane lipid content was also assessed. Results: The concentration of sphingomyelin was higher in the membrane of the hypertensive rats (45.7 ± 6 v 22.4 ± 2 μg/mg of protein) compared to control. The previously observed increase in membrane arachidonic acid content was observed in hypertensive animals when compared to control (130 ± 32 v 40 ± 3 μg/mg of protein). However, this difference was confined to the phosphatidylinositol (18 ± 4 v 6.5 ± 1.5 μg/mg of protein) and free fatty acid (2.1 ± 0.4 v 0.6 ± 0.1 μg/mg of protein) fractions. Conclusion: We hypothesize that reports of reduced membrane fluidity observed in hypertension may be due to an increase in the proportion of sphingomyelin in the cell membrane.

KW - Erythrocytes

KW - Genetic hypertension

KW - Membrane lipids

UR - http://www.scopus.com/inward/record.url?scp=0034766290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034766290&partnerID=8YFLogxK

U2 - 10.1016/S0895-7061(01)02188-4

DO - 10.1016/S0895-7061(01)02188-4

M3 - Article

VL - 14

SP - 1149

EP - 1153

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 11 I

ER -